TSM has nearly doubled in a year, but AI-driven growth, tight capacity and a 30%+ 2026 revenue outlook raise questions about how far it can run.
Will HYPE eye $80 amid renewed spot ETF inflows?
MU and STX have surged on AI-driven demand, with strong revenue growth, pricing power and expanding profitability supporting further momentum.
Ethereum is holding near $1,800 as traders watch the Fed decision, dot plot, and Kevin Warsh's first major policy signal as chair.
CoreWeave TodayCRWVCoreWeave$115.25 -1.78 (-1.52%) As of 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$63.80▼$187.00Price Target$131.52Add to WatchlistThere's nothing quite like the headline "insiders dump billions" to get investors reaching for the sell button.
Hollywood A-lister Matt Damon is slated to appear at the upcoming Ripple Swell conference. The much-anticipated event, which will take place in New York for the second year in a row, has been scheduled for Oct. 27–29.
Investors need to pay close attention to CCNE stock based on the movements in the options market lately.
On Tuesday's TBPN, the conversation drifted from SpaceX's eye-watering private mark to Snap's eye-watering hardware price tag.
According to the Census Bureau's Advance Retail Sales Report, consumer spending climbed for the fourth straight month in May. Headline sales rose 0.9%, almost double the projected 0.5% growth and marking an acceleration from April's 0.4% rise.
Bitwise advisor Jeff Park says investors should start thinking less about Bitcoin's (CRYPTO: BTC) upside speculation and more about the risk of not owning it at all. “If You Don't Own Bitcoin, You're Basically Short BTC” In a "When Shift Happens" interview clip published on June 17, Park argued that Bitcoin remains a hedge against fiat currency debasement.
Victoria's Secret & Co. (NYSE:VSCO) could continue delivering strong earnings growth as sustained sales momentum supports margin expansion, according to Bank of America, which maintained its ‘Buy' rating on the retailer. Bank of America analysts wrote that recent sales trends have eased concerns about a potential slowdown following the company's first-quarter earnings beat and increased full-year guidance.
Struggling Queens-based carrier said it is shifting resources to booming South Florida in its latest bid to restore profitability.
I rate Palantir Technologies a Buy with a $183 price target, implying 41% upside from current levels. My main growth drivers are US Commercial AIP adoption, government and defense AI, sovereign AI infrastructure software, and enterprise renewals across new verticals. I believe these growth drivers support an estimated 2028 EPS estimate of about $2.26.
Investors in the semiconductor capital equipment sector often face a structural question about where value is created in the supply chain.
Aurora Spine Corporation (ASG:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Bitcoin climbed above the $66,000 mark on Wednesday after U.S. President Donald Trump provided new details about the emerging U.S.-Iran agreement during a press conference at the G7 Summit, fueling optimism across global financial markets. The cryptocurrency market reacted positively as Trump outlined key elements of a Memorandum of Understanding (MOU) between the United States and Iran.
Don Lair writes about options income, dividend strategy, and the kind of boring-but-durable investing that actually funds retirement.
The Macro Shift: Generative AI built on traditional silicon is approaching a literal power and physical limitation wall. Quantum computing is one of the most credible next-step technologies. The Catalyst: Quantum Computing is waiting for its breakout moment. The U.S. Commerce Department just threw a $2 billion bag of CHIPS Act cash at the quantum sector. The Edge: I rate the WisdomTree Quantum Computing Fund (WQTM) as a Buy. It wraps the top quantum names with the largest moats into a diversified basket.
The succession will mark the end of an era for the derivatives exchange, which transformed under Duffy's long run.
CL leverages pricing power, premium innovation and productivity initiatives to drive growth, expand margins and strengthen brand momentum.
June is shaping up as a stock-picker's month. Spring volatility has settled, and contrarian investors are scanning the wreckage for quality names trading well off their highs with identifiable recovery catalysts.
Shares of Robinhood (NASDAQ:HOOD | HOOD Price Prediction) are surging in midday trading on Wednesday, June 17, with the stock up 12% to roughly $109.
AeroVironment, Inc. (NASDAQ:AVAV) will report fiscal fourth-quarter earnings after the market closes on Monday, June 29.
Botanix's shutdown has raised an uncomfortable question for Bitcoin builders: Does the market actually want programmable BTC, or just a better way to borrow, lend and earn yield on it?
Fed removes easing bias and silver falls as traders price out 2026 rate cuts, putting the 200-day moving average at $68.72 in focus.
Among the various corners of the stock market, few have attracted as much attention as rare-earth element companies. This comes as the global economy looks to loosen China's grip on this market by investing in non-Chinese supply chains.
Blue Owl Capital remains a hold as macro uncertainty and tight dividend coverage offset improved liquidity and leverage. OBDC trades at a 22.5% discount to NAV and offers an 11% forward dividend yield after a recent 16% dividend cut. Leverage improved to 1.13x, non-accruals declined, and Moody's upgraded OBDC to Baa2, enhancing balance sheet strength.
Vanda Research's Viraj Patel walked CNBC viewers through one of the strangest sessions of the year on June 16, with a direct message: Retail investors sold the rest of the market to fund a single bet on SpaceX (NASDAQ:SPCX).
Pfizer Inc. remains a Buy with 55%+ upside potential over two years, driven by a robust pipeline and undervalued forward earnings. PFE's Q1 2026 results beat estimates, with non-COVID sales up 7% YoY and strong contributions from Seagen and new product launches. Key catalysts include the potential blockbuster GLP-1 candidate berobenatide, aggressive oncology growth, and patent settlements extending revenue streams.
QCP warns Strategy's note buyback and dividend pressure keep Bitcoin capped below $66,000.